Navigation Links
ISTA Pharmaceuticals Announces Conference Call and Webcast of Second Quarter 2009 Financial Results
Date:7/29/2009

IRVINE, Calif., July 29 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will release second quarter 2009 financial results after market close on August 5, 2009. In conjunction, the Company will host a conference call at 5:00 p.m. Eastern Time to discuss these results and provide a pipeline update.

    Date: Wednesday, August 5, 2009
    Time: 5:00 p.m. Eastern Time

    Conference call access:
    Internet:  www.istavision.com
    Domestic dial-in:  866-700-7441
    International dial-in:  617-213-8839
    Passcode:  50706656

To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 37779170. This conference call also will be webcast live and archived on ISTA's website until September 5, 2009.

About ISTA Pharmaceuticals

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $5.1 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website athttp://www.istavision.com.

Web site: http://www.istavision.com


'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
2. Poniard Pharmaceuticals to Present at Two Upcoming Investor Conferences in August
3. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, August 3, 2009
4. Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook
5. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
6. Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
7. Millennium Pharmaceuticals Inc./Lymphoma Research Foundation funds lymphoma research
8. Quark Pharmaceuticals Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma
9. Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
10. Sunesis Pharmaceuticals Appoints Helen S. Kim to Board of Directors
11. Hisamitsu Pharmaceutical Co., Inc. Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... 23, 2017 , ... Moisture measurement is a necessary process ... paramount to success. Selecting an inappropriate measurement method can cause costly errors, and ... same equipment. Rare or expensive substances are wasted and production may even be ...
(Date:1/23/2017)... ... 2017 , ... "ProRandom is a set of camera tools that allow video editors to integrate ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , With ProRandom, ... video footage. ProRandom works by using a virtual camera to create the illusion of ...
(Date:1/23/2017)... , ... January 23, 2017 ... ... Foundation (OREF), in partnership with the American Society of Anesthesiologists® (ASA®), the ... (APSF), the American Academy of Orthopaedic Surgeons (AAOS) and the Cigna Foundation, ...
(Date:1/23/2017)... ... ... Inn at the Mill”: a story of love and redemption, hope and uncertainty as ... content. , “The Inn at the Mill” is the creation of published author, Lois ... is now living in Berks County on Crow Hill. The inn, the mill ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... and resources at seafoodnutrition.org/programs and seafoodnutrition.org/resources to assist in teaching communities and ... resources have been developed for use by nutrition educators and influencers within ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 23, 2017 Varias proteínas ... enal) y el riesgo de diálisis ... pabetalone    Resverlogix Corp. ("Resverlogix" o ... de un ensayo en fase 1 con sede en ... (renal) severa. Los datos demostraron unos resultados importantes en ...
(Date:1/23/2017)... , January 23, 2017 A new Transparency ... Market was valued at US$0.53 bn in 2013 and is ... strong 17.50% CAGR between 2014 and 2022. The title of the ... Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022." ... Non-invasive prenatal testing (NIPT), ...
(Date:1/23/2017)... 2017  ResMed (NYSE : RMD), BMC (Pékin, Chine) et ... aujourd,hui qu,ils se sont mis d,accord sur le règlement ... BMC et 3B seront autorisés à vendre leurs produits ... et ResMed effectuera le paiement de la décision en ... de Floride entre les deux parties. Le règlement n,inclut ...
Breaking Medicine Technology: